CODX Shareholder Update: Robbins LLP Urges Shareholders with Significant Losses in Co-Diagnostics, Inc. (CODX) to Inquire About Becoming Lead Plaintiff SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities...

Co-Diagnostics, Inc. Investors: Company Investigated by the Portnoy Law Firm Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Aug. 23, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Co-Diagnostics, Inc. (“Co-Dx”...

Kaplan Fox Files Class Action Against Co-Diagnostics, Inc. (CODX) And Encourages Investors with Substantial Losses to Contact the Firm NEW YORK, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a class action suit in the United States District Court for the Southern District of New...

To the Investors of CODX: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Co-Diagnostics, Inc. (CODX) SAN DIEGO, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that...

Co-Diagnostics, Inc. Investors, Have You Suffered Losses on Your Investment? You may be eligible to participate in a class action to recover your losses and protect the stock market Click here to contact the Portnoy Law Firm and participate in the action. LOS ANGELES, June 15, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Co-Diagnostics, Inc. (NASDAQ: CODX) investors...